Literature DB >> 12197486

Is caspase-8 a neuroendocrine lung tumor suppressor?

Suparna Mazumder1, Alexandru Almasan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12197486      PMCID： PMC2519113          DOI： 10.4161/cbt.1.1.46

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  18 in total

Review 1.  Apoptosis-regulating proteins as targets for drug discovery.

Authors:  J C Reed
Journal:  Trends Mol Med       Date:  2001-07       Impact factor: 11.951

Review 2.  DNA methylation, methyltransferases, and cancer.

Authors:  K D Robertson
Journal:  Oncogene       Date:  2001-05-28       Impact factor: 9.867

3.  Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung.

Authors:  H Dosaka-Akita; P T Cagle; H Hiroumi; M Fujita; M Yamashita; A Sharma; Y Kawakami; W F Benedict
Journal:  Cancer       Date:  2000-02-01       Impact factor: 6.860

4.  Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN.

Authors:  T Teitz; T Wei; M B Valentine; E F Vanin; J Grenet; V A Valentine; F G Behm; A T Look; J M Lahti; V J Kidd
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

5.  Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer.

Authors:  M J Fisher; A K Virmani; L Wu; R Aplenc; J C Harper; S M Powell; T R Rebbeck; D Sidransky; A F Gazdar; W S El-Deiry
Journal:  Clin Cancer Res       Date:  2001-06       Impact factor: 12.531

6.  Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer.

Authors:  S Fulda; M U Küfer; E Meyer; F van Valen; B Dockhorn-Dworniczak; K M Debatin
Journal:  Oncogene       Date:  2001-09-13       Impact factor: 9.867

7.  Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

Authors:  F C Kischkel; D A Lawrence; A Chuntharapai; P Schow; K J Kim; A Ashkenazi
Journal:  Immunity       Date:  2000-06       Impact factor: 31.745

Review 8.  The Pezcoller lecture: cancer cell cycles revisited.

Authors:  C J Sherr
Journal:  Cancer Res       Date:  2000-07-15       Impact factor: 12.701

9.  Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8.

Authors:  F C Kischkel; D A Lawrence; A Tinel; H LeBlanc; A Virmani; P Schow; A Gazdar; J Blenis; D Arnott; A Ashkenazi
Journal:  J Biol Chem       Date:  2001-10-02       Impact factor: 5.157

10.  Homozygous deletion at chromosome 2q33 in human small-cell lung carcinoma identified by arbitrarily primed PCR genomic fingerprinting.

Authors:  T Kohno; K Morishita; H Takano; D N Shapiro; J Yokota
Journal:  Oncogene       Date:  1994-01       Impact factor: 9.867
View more
  3 in total

Review 1.  Molecular pathology of tumor metastasis III. Target array and combinatorial therapies.

Authors:  József Tímár; Andrea Ladányi; István Peták; András Jeney; László Kopper
Journal:  Pathol Oncol Res       Date:  2003-04-18       Impact factor: 3.201

2.  Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines.

Authors:  Francisco Sánchez-Vega; Valer Gotea; Hanna M Petrykowska; Gennady Margolin; Thomas C Krivak; Julie A DeLoia; Daphne W Bell; Laura Elnitski
Journal:  Epigenetics       Date:  2013-10-22       Impact factor: 4.528

3.  The enigmatic roles of caspases in tumor development.

Authors:  Richard Jäger; Ralf M Zwacka
Journal:  Cancers (Basel)       Date:  2010-11-24       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.